Pdt Partners, LLC 89bio, Inc. Transaction History
Pdt Partners, LLC
- $1 Billion
- Q4 2024
A detailed history of Pdt Partners, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 80,918 shares of ETNB stock, worth $689,421. This represents 0.06% of its overall portfolio holdings.
Number of Shares
80,918
Previous 169,245
52.19%
Holding current value
$689,421
Previous $1.25 Million
50.48%
% of portfolio
0.06%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding ETNB
# of Institutions
172Shares Held
124MCall Options Held
78.7KPut Options Held
979K-
Janus Henderson Group PLC London, X016.5MShares$141 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$121 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$86.9 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$63.7 Million0.94% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$59.8 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $396M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...